Cited by 22Endometrial and Cervical Cancer TreatmentsLymphatic System and DiseasesBreast Cancer Treatment Studies

Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer

Wakayama, Akihiko, Kudaka, Wataru, Matsumoto, Hirofumi, Aoyama, Hajime, Ooyama, Takuma, Taira, Yusuke, Arakaki, Yoshihisa, Shimoji, Yuko +6 more·2018·International Journal of Clinical Oncology

Abstract

Background Lymphovascular space involvement is reported to be an important risk factor in endometrial cancer. This study was conducted to evaluate the separate prognostic effects of lymphatic invasion and venous invasion on the outcomes of patients with endometrial cancer. Methods From 2006 to 2013, 189 histologically confirmed endometrial cancer patients were examined. To study the venous invasion (v) of the endometrial cancer, Victoria blue-H&E staining-which positively stains the elastic fibers of vessels-was performed. Immunohistochemical staining with D2-40 was used to study the lymphatic invasion (ly) of the endometrial cancer. Results The median age of the patients was 57 (range 25-84) years. ly(+) and/or v(+) patients were significantly more likely to present an advanced cancer stage, G3 tumor, and deep myometrial invasion than ly(-)/v(-) patients. The incidence of lymph node metastasis was high in ly(+) patients, and that of ovarian metastasis was high in v(+) patients. Lymphatic vessel invasion was significantly correlated with regional lymph node metastasis. We found a significantly higher incidence of distant metastasis in ly(+) patients. Most recurrences in ly(+)/v(-) patients occurred in lymph nodes, while those in ly(+)/v(+) patients occurred mainly at distant organs. Finally, the prognosis was significantly poorer for ly(+) patients, in whom lymphatic invasion was an independent prognostic factor along with distant metastasis. Conclusions Our study suggests th…

Integrity signals

Registry

Crossref · 10.1007/s10147-017-1227-6

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wakayama, A., Kudaka, W., Matsumoto, H., Aoyama, H., Ooyama, T., Taira, Y., Arakaki, Y., Shimoji, Y., Nakasone, T., Nishihira, K., Kaneshima, I., Tamaki, T., Yoshimi, N., & Aoki, Y.
Affiliations
  • University of the Ryukyus (JP)
  • University of the Ryukyus University Hospital (JP)
Corresponding author
Aoki, Yoichi
Venue
International Journal of Clinical Oncology
Published
2017-12-23
Volume
23
Issue
3
Pages
532-538
ISSN
  • 1341-9625 (ISSN-L)
  • 1437-7772
OpenAlex
W2778482211
Cited by
22
References
1
Citations by year
2026: 2 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 2 · 2019: 1 · 2018: 2
FWCI
1.61
Type
journal article
Language
en
Open access
closed
Locations
  • International Journal of Clinical Oncology (publishedVersion)
  • PubMed (publishedVersion)
  • University of the Ryukyus academic repository (University of the Ryukyus) (submittedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
  • Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords
endometrial cancer, lymphatic vessel invasion, venous invasion, lymph node metastasis, prognostic factors, distant metastasis, recurrence site, D2-40, lymphovascular space involvement
MeSH terms
Adult, Aged, Aged, 80 and over, Female, Follow-Up Studies, Humans, Immunohistochemistry, Lymph Nodes, Lymphatic Metastasis, Middle Aged, Myometrium, Neoplasm Recurrence, Local, Ovarian Neoplasms, Prognosis, Risk Factors, Survival Rate, Endometrial Neoplasms, Lymphatic Vessels

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review